Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Buy
73
STVN Quote, Financials, Valuation and Earnings
Last price:
$22.51
Seasonality move
:
-5.95%
Day range:
$21.75 - $22.59
52-week range:
$16.56 - $33.49
Dividend yield:
0.26%
P/E ratio:
47.39x
P/S ratio:
5.11x
P/B ratio:
4.20x
Volume:
328.8K
Avg. volume:
356.5K
1-year change:
-20.49%
Market cap:
$6.1B
Revenue:
$1.2B
EPS (TTM):
$0.48
Analysts' Opinion
-
Consensus RatingStevanato Group SpA has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $26.84, Stevanato Group SpA has an estimated upside of 19.23% from its current price of $22.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $21.00 representing 6.71% downside risk from its current price of $22.51.
Fair Value
-
According to the consensus of 8 analysts, Stevanato Group SpA has 19.23% upside to fair value with a price target of $26.84 per share.
STVN vs. S&P 500
-
Over the past 5 trading days, Stevanato Group SpA has overperformed the S&P 500 by 11.81% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Stevanato Group SpA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Stevanato Group SpA has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Stevanato Group SpA reported revenues of $352.4M.
Earnings Growth
-
Stevanato Group SpA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Stevanato Group SpA reported earnings per share of $0.19.
Enterprise value:
6.5B
EV / Invested capital:
3.42x
Price / LTM sales:
5.11x
EV / EBIT:
35.84x
EV / Revenue:
5.42x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-37.88x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
22.04x
Gross Profit (TTM):
$326.8M
Return On Assets:
5.33%
Net Income Margin (TTM):
10.65%
Return On Equity:
9.13%
Return On Invested Capital:
7.08%
Operating Margin:
20.22%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1B | $1.2B | $1.2B | $345.3M | $352.4M | |
| Gross Profit | $335.7M | $367.9M | $326.8M | $109.7M | $104.6M | |
| Operating Income | $201.7M | $217.3M | $174M | $69M | $71.3M | |
| EBITDA | $235.2M | $293.2M | $293.5M | $65M | $72.1M | |
| Diluted EPS | $0.57 | $0.60 | $0.48 | $0.18 | $0.19 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $606.1M | $980.5M | $907M | $952.7M | $915.8M | |
| Total Assets | $1.2B | $1.6B | $1.8B | $2.3B | $2.4B | |
| Current Liabilities | $388.9M | $383.4M | $496M | $634.9M | $496.8M | |
| Total Liabilities | $809.1M | $653.5M | $711.8M | $1B | $961.9M | |
| Total Equity | $381.5M | $952.9M | $1.1B | $1.3B | $1.5B | |
| Total Debt | $415M | $250.4M | $212.7M | $417.4M | $428.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $109M | $113.9M | $168.6M | $10.5M | -$57.9M | |
| Cash From Investing | -$256.2M | -$456M | -$335.8M | -$97.9M | $94M | |
| Cash From Financing | -$47M | $171.1M | $198.3M | $94.5M | -$26.5M | |
| Free Cash Flow | -$147.4M | -$364.5M | -$170.8M | -$468M | $39.5M | |
STVN
Sector
Market Cap
$6.1B
$39.2M
Price % of 52-Week High
67.21%
45.99%
Dividend Yield
0.26%
0%
Shareholder Yield
-3.28%
-0.81%
1-Year Price Total Return
-20.49%
-38.63%
Beta (5-Year)
--
0.774
Dividend yield:
0.26%
Annualized payout:
$0.06
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$21.01
200-day SMA
Buy
Level
$20.23
Bollinger Bands (100)
Buy
Level
19.43 - 22.43
Chaikin Money Flow
Buy
Level
11.8M
20-day SMA
Buy
Level
$20.49
Relative Strength Index (RSI14)
Buy
Level
59.65
ADX Line
Buy
Level
16.59
Williams %R
Sell
Level
-3.5343
50-day SMA
Buy
Level
$21.18
MACD (12, 26)
Buy
Level
0.23
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Neutral
Level
15.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.1751)
Buy
CA Score
(Annual)
Level (0.4271)
Buy
Beneish M-Score
(Annual)
Level (-2.4943)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.0231)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
Stock Forecast FAQ
In the current month, STVN has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The STVN average analyst price target in the past 3 months is $26.84.
-
Where Will Stevanato Group SpA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Stevanato Group SpA share price will rise to $26.84 per share over the next 12 months.
-
What Do Analysts Say About Stevanato Group SpA?
Analysts are divided on their view about Stevanato Group SpA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Stevanato Group SpA is a Sell and believe this share price will drop from its current level to $21.00.
-
What Is Stevanato Group SpA's Price Target?
The price target for Stevanato Group SpA over the next 1-year time period is forecast to be $26.84 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is STVN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Stevanato Group SpA is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of STVN?
You can purchase shares of Stevanato Group SpA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Stevanato Group SpA shares.
-
What Is The Stevanato Group SpA Share Price Today?
Stevanato Group SpA was last trading at $22.51 per share. This represents the most recent stock quote for Stevanato Group SpA. Yesterday, Stevanato Group SpA closed at $22.51 per share.
-
How To Buy Stevanato Group SpA Stock Online?
In order to purchase Stevanato Group SpA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 24
Regencell Bioscience Holdings [RGC] is down 4.49% over the past day.
Sell
36
VMI alert for Mar 24
Valmont Industries [VMI] is up 5.15% over the past day.
Buy
61
ALNY alert for Mar 24
Alnylam Pharmaceuticals [ALNY] is up 4.01% over the past day.
